Catalyst Wire Dossier Catalyst Wire Dossier

Telapristone Acetate

telapristone acetate · Repros Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Telapristone Acetate, covering 2019-07-23 to 2023-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy [Phase 2]

See pricing